(Crystal Proenza is associate editor of RealEstateFlorida.)

|

MIAMI-Becton Dickinson and Co., a New Jersey-based globalmedical technology company, plans to invest $20 million to open a90,000-sf biosciences manufacturing facility in a building formerlyused by IVAX Pharmaceuticals. The new facility will be used toproduce cell culture media supplements for production of vaccinesand biopharmaceuticals, and is expected to create 75 high-payingjobs and $3.3 million in new tax revenue over the next eight yearsfor Miami-Dade County's school system and general fund.

|

"Worldwide demand is increasing for our cell culture mediasupplements that are used in the production of biologicalmedicines," Tom Isett, vice president of advanced bioprocessing forBD, stated in a release. "Miami-Dade County, with its spirit ofpublic-private partnership, skilled workforce and infrastructure,is an ideal location for BD to grow this important part of ourbusiness."

|

The Beacon Council, Miami-Dade County's economic developmentpartnership, recruited the company for the building. The agencyhelped secure local and state incentives totaling $1.4 millionrelated to investment and job creation commitments.

|

"The new BD facility contributes to our ongoing effort ofincreasing economic growth through the recruitment and retention oflife-science companies," said Frank Nero, president and CEO of theBeacon Council. "In order for Miami-Dade to remain competitive inthe knowledge-based economy, we need to continue to produce askilled workforce attractive to high-tech and advancedindustries."

Want to continue reading?
Become a Free ALM Digital Reader.

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.